Ipswich Investment Management Co., Inc. - REGENXBIO INC ownership

REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 179 filers reported holding REGENXBIO INC in Q2 2018. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.

Quarter-by-quarter ownership
Ipswich Investment Management Co., Inc. ownership history of REGENXBIO INC
ValueSharesWeighting
Q1 2019$1,670,000
+34.0%
29,132
-1.9%
0.55%
+19.5%
Q4 2018$1,246,000
-44.9%
29,702
-0.8%
0.46%
-40.2%
Q3 2018$2,260,000
+0.7%
29,932
-4.3%
0.76%
-25.9%
Q2 2018$2,244,000
+243.6%
31,271
+42.9%
1.03%
+274.9%
Q1 2018$653,000
-10.3%
21,885
+0.0%
0.28%
-10.7%
Q4 2017$728,00021,8800.31%
Other shareholders
REGENXBIO INC shareholders Q2 2018
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 831,014$15,714,4756.51%
MPM BioImpact LLC 617,671$11,680,1593.03%
Sonic GP LLC 193,079$3,651,1242.79%
ArchPoint Investors 224,278$4,241,0971.84%
Redmile Group, LLC 1,640,725$31,026,1101.35%
MIRABELLA FINANCIAL SERVICES LLP 25,983$5,461,3440.83%
WS MANAGEMENT LLLP 396,997$7,507,2130.79%
Redwood Wealth Management Group, LLC 15,190$287,2430.33%
SummerHaven Investment Management, LLC 27,503$520,0820.30%
Lombard Odier Asset Management (Switzerland) SA 130,369$2,465,2780.22%
View complete list of REGENXBIO INC shareholders